RYBELSUS

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: 23cd06adbc24a314
Drug Approval Canada Name: RYBELSUS
Product Name: RYBELSUS
Status: Marketed
Status Date: 2020-04-19
Original Market Date: 2020-04-19
Din: 02497611
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription , Schedule D
Ahfs: 68:20.06
Atc Original: A10BJ06 SEMAGLUTIDE
Atc Name: a 10 bj 06
Aig Number: 0159870005
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

SEMAGLUTIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

23cd06adbc24a314

Type

Standard